March 1, 2017

Corticosteroids, High-Dose Pulmicort Both Effective Therapies for Mild-to-Moderate Crohn’s

News

Treatment with corticosteroids and high-dose Pulmicort (budesonide) are both effective induction therapies for patients with mild-to-moderate Crohn’s disease, though high-dose Asacol (mesalamine) also offers an effective alternative with fewer side effects. ... Read more

November 3, 2014September 28, 2016

Celltrion Healthcare Presents Clinical Data Showing That Inflammatory Bowel Disease Patients Should Be Treated With Biosimilar Monoclonal Antibody (mAb) Infliximab

IBD News, News

Documented clinical experience was recently presented by Celltrion Healthcare’s satellite symposium during the 2014 United European Gastroenterology (UEGW) showing evidence that patients with inflammatory bowel disease (IBD) — Crohn’s disease and ulcerative colitis — should be treated with the biosimilar monoclonal antibody (mAb) infliximab. ... Read more